3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
6
Peritoneal Neoplasms
4
Ovarian Neoplasms
4
Neoplasm Metastasis
3
Pancreatic Neoplasms
2
Neoplasms
2
Gastric Adenocarcinoma
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Stomach Diseases
1
Pseudomyxoma Peritonei
1
Peritoneal Diseases
1
Hyperthermic Intraperitoneal Chemotherapy
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Fallopian Tube Neoplasms
1
Digestive System Neoplasms
1
Colonic Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Oxaliplatin
13
Bevacizumab
11
Capecitabine
10
Fluorouracil
8
Blood Specimen Collection
8
Leucovorin
7
Cetuximab
7
Folfox protocol
6
pembrolizumab
5
Drug Therapy
5
trifluridine tipiracil drug combination
4
dostarlimab
4
Nivolumab
4
Irinotecan
4
HMPL-013
4
fludarabine
3
XELOX
3
Specimen Handling
3
IFL protocol
3
Cyclophosphamide
3
Biopsy
3
toripalimab
2
tislelizumab
2
tipiracil
2
regorafenib
2
pertuzumab
2
envafolimab
2
encorafenib
2
cemiplimab
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Colonic Neoplasms
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT05250648
2024-10-09
GECOP-MMC
Hospital Universitario de Fuenlabrada
Phase 4
Recruiting
216 enrolled